Fu Helen, McMahon Siobhan K, Gross Cynthia R, Adam Terrence J, Wyman Jean F
School of Nursing, University of Minnesota, Minneapolis, MN, United States.
School of Nursing, University of Minnesota, Minneapolis, MN, United States.
Diabetes Res Clin Pract. 2017 Sep;131:70-81. doi: 10.1016/j.diabres.2017.06.016. Epub 2017 Jun 21.
To assess the usability and clinical effectiveness of diabetes mobile applications (diabetes apps) developed for adults with type 2 diabetes.
A systematic review of the usability and effectiveness of diabetes apps was conducted. Searches were performed using MEDLINE, EMBASE, COMPENDEX, and IEEE XPLORE for articles published from January 1, 2011, to January 17, 2017. Search terms included: diabetes, mobile apps, and mobile health (mHealth).
The search yielded 723 abstracts of which seven usability studies and ten clinical effectiveness studies met the inclusion criteria from 20 publications. Usability, as measured by satisfaction ratings from experts and patients, ranged from 38% to 80%. Usability problem ratings ranged from moderate to catastrophic. Top usability problems are multi-steps task, limited functionality and interaction, and difficult system navigation. Clinical effectiveness, measured by reductions in HbA1c, ranged from 0.15% to 1.9%.
Despite meager satisfaction ratings and major usability problems, there is some limited evidence supporting the effectiveness of diabetes apps to improve glycemic control for adults with type 2 diabetes. Findings strongly suggest that efforts to improve user satisfaction, incorporate established principles of health behavior change, and match apps to user characteristics will increase the therapeutic impact of diabetes apps.
评估为2型糖尿病成人患者开发的糖尿病移动应用程序(糖尿病应用)的可用性和临床效果。
对糖尿病应用的可用性和有效性进行系统评价。使用MEDLINE、EMBASE、COMPENDEX和IEEE XPLORE检索2011年1月1日至2017年1月17日发表的文章。检索词包括:糖尿病、移动应用和移动健康(mHealth)。
检索得到723篇摘要,其中7项可用性研究和10项临床有效性研究符合20篇出版物的纳入标准。根据专家和患者的满意度评分衡量,可用性范围为38%至80%。可用性问题评分从中度到严重。最主要的可用性问题是多步骤任务、功能和交互受限以及系统导航困难。以糖化血红蛋白(HbA1c)降低幅度衡量的临床效果范围为0.15%至1.9%。
尽管满意度评分较低且存在主要的可用性问题,但有一些有限的证据支持糖尿病应用对改善2型糖尿病成人患者血糖控制的有效性。研究结果强烈表明,努力提高用户满意度、纳入已确立的健康行为改变原则以及使应用与用户特征相匹配,将增加糖尿病应用的治疗效果。